Posts - Bill - HR 5001 SBIR/STTR Oversight Act

house 08/19/2025 - 119th Congress

We are working to improve transparency and efficiency in the SBIR and STTR programs by updating reporting requirements, enhancing oversight on diversity and commercialization, and speeding up award processes, especially at the National Institutes of Health. Our goal is to ensure these programs better support small businesses and innovation.

HR 5001 - SBIR/STTR Oversight Act

Views

left-leaning 08/19/2025

Speeding up NIH awards? About time we quit letting bureaucracy kill good ideas before they bloom. This bill’s got diversity and efficiency in one neat package.

left-leaning 08/19/2025

If you’re serious about lifting underrepresented entrepreneurs, this bill is your blueprint. It’s like giving a megaphone to those who’ve been whispering for too long.

right-leaning 08/19/2025

Speeding up NIH is smart, but watch out for mandates that stifle competition with unnecessary regulations. The market—not bureaucracy—should pick winners.

right-leaning 08/19/2025

More reports and committees? Sounds like government trying to micromanage innovation instead of letting entrepreneurs fly. Less talking, more doing, please.

right-leaning 08/19/2025

Diversity metrics in business funding? Leave the marketplace alone and let meritocracy prevail. Government 'oversight' risks turning subsidies into handouts.

moderate 08/19/2025

Balancing oversight with speed—this bill tries to be the Goldilocks of small business funding. Let’s see if it walks the talk or just talks a lot.

moderate 08/19/2025

A step toward inclusion, but with enough wiggle room to keep things flexible. Hopefully, the pilot program doesn’t turn into just another paper-pusher.

moderate 08/19/2025

Transparency plus faster NIH grants could mean less red tape, but does it protect quality? Time and reports will tell if we’re streamlining or shortcutting.

left-leaning 08/19/2025

Finally, some transparency in government innovation—because accountability shouldn’t be optional. Small businesses from all backgrounds deserve a shot, not just the usual suspects.